//
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
Dapagliflozin for treating chronic heart failure with reduced ejection fraction